Imarc
This presentation is the property of its rightful owner.
Sponsored Links
1 / 11

US Generic Drug Market Research Report 2016 - 2021 PowerPoint PPT Presentation


This report provides a comprehensive insight into the historical and current trends as well as the future prospects of the generic drug market in the US. To get more click: http://www.imarcgroup.com/us-generics-market

Download Presentation

US Generic Drug Market Research Report 2016 - 2021

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Consulting Services

US Generic Drug Market

to Reach US$ 141.5

Billion by 2021

Copyright © 2016 International Market Analysis Research & Consulting (IMARC). All Rights Reserved


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report DescriptionAbout IMARC Group

The International Market Analysis Research and Consulting Group is a leading advisor on management

strategy and market research worldwide. We partner with clients in all sectors and regions to identify

their highest-value opportunities, address their most critical challenges, and transform their

businesses.

IMARC’s information products include major market, scientific, economic and technological

developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food

and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the

company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and

markets with close cooperation at all levels of the client organization. This ensures that our clients

achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting

results.


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report Description and Highlights

Report Description

US Generic Drug Market to Reach US$ 141.5 Billion by 2021

Generic drugs have low research & development requirements. As a result, the costs involved in

developing and manufacturing them are significantly lower than their branded counterparts. This allows

generic manufacturers to price their drugs considerably lower compared to branded drugs. This has

ultimately enabled the government, third-party payers and patients to save billions of dollars on

healthcare expenditures.

A recently released report by IMARC Group titled “US Generic Drug Market – Industry Trends,

Competitive Landscape, Opportunities and Outlook” provides a deep insight into the generic drugs

market in the US. Over the last three decades, the US generic drug market has experienced robust

growth and currently represents the world’s biggest market for generic drugs. From less than 20% of the

total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the

US. The report cites several factors that are currently catalysing the growth of the US generic drug

market. One of the major factors that has contributed to the growth of this market is the patent expiry of

a number of blockbuster branded drugs. Once branded drugs go off-patent, manufacturers can launch

generic versions of these drugs. As these drugs have low research & development requirements, the

costs involved in developing and manufacturing them are significantly lower than branded drugs. This

allows generic manufacturers to price their drugs considerably lower compared to branded drugs. This

has ultimately enabled the government, third-party payers and patients to save billions of dollars on

healthcare expenditures. Other growth inducing factors include aging population, increasing prevalence

of chronic diseases and incentives offered to physicians and pharmacists to promote generics.


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report Description and Highlights

Report Description

Browse press release: http://www.imarcgroup.com/us-generic-drug-market

According to the report, the market for generic drugs in the US reached values worth US$ 74.5 Billion in

2015, representing a CAGR of 13.3% during 2010-2015. Estimates by IMARC Group further suggest that

the market is expected to grow at a CAGR of 11% during 2016-2021 reaching figures worth US$ 141.5

Billion by 2021.

The report has bifurcated the market on the basis of branded and unbranded generics. Currently,

unbranded generics dominate the market and account for the majority of the total generic prescription

volumes. The report has further segmented the market on the basis of distribution. Some of the key

purchasers of generic drugs in the US include Red Oak Sourcing, Walgreens Boots Alliance, McKesson One

Stop, Econdisc Contracting Solutions, etc. The report has also provided a detailed competitive landscape

analysis covering the key players operating in this market. At present, Teva represents the largest generic

manufacturer in the US accounting for around a fifth of the total generic sales. Other major players

include: Mylan Labs Inc., Sandoz, Endo/Par and Sun Pharmaceutical.

This report provides a comprehensive insight into the historical and current trends as well as the future

prospects of the generic drug market in the US. This study serves as an exceptional tool to understand the

sales trends, volume trends, growth, key segments, competitive structure, regulations, major

manufacturer, major distributors, top drugs, manufacturing requirements, opportunities and future

prospects of the US generic drug market. This report can serve as an excellent guide for manufacturers,

consultants, researchers, marketing strategists and all those who plan to foray into the US generic drug

market in any form.


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report Description and Highlights

Report Description

Enquiry for sample report or more details, click here: http://www.imarcgroup.com/enquiry-form/

Table of Contents

1 Research Methodology and Market Definitions

2 Report Summary

3 US Generic Drug Market – Introduction

3.1 What are Generic Drugs?

3.2 Unbranded and Branded Generics

3.3 Authorized Generics

3.4 Commoditized and Specialty Generics

4 Why is the US Generic Drug Market so Lucrative

4.1 Patent Expiry of Blockbuster Drugs

4.2 Significant Price Differential between Generics and Innovator Drugs

4.3 Savings for the Government and Third Party Payers

4.4 Incentives for Dispensing and Prescribing Generic Drugs

4.5 Reimbursement and Lower Copayments

4.6 Biosimilars

5 Global Generic Drug Market

5.1 Current and Historical Market Trends

5.2 Market Breakup by Country: The United States Represents the World’s Biggest Market


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report Description and Highlights

Report Description

5.3 Market Forecast

5.4 Most Prescribed Generic and Branded Drugs

List of Figures

Figure 3 1: Structure of the Pharmaceutical Industry

Figure 3 2: Classification of Generic Drugs

Figure 4 1: US: Patent Expiry Exposure (in Billion US$), 2009-2018

Figure 4 2: US: Savings from Generic Drugs (in Billion US$), 2005-2015

Figure 5 1: Global: Generic Drug Market: Sales Value (in Billion US$), 2010-2015

Figure 5 2: Global: Generic Drug Market: Sales Volume (in Billion Units), 2010-2015

Figure 5 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2015

Figure 5 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2015

Figure 5 5: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2016-2021

Figure 5 6: Global: Generic Drug Market: Sales Volume (in Billion Units), 2016-2021

Figure 6 1: US: Pharmaceutical Market: Sales Volume (in Billion Units), 2010-2015

Figure 6 2: US: Pharmaceutical Market: Sales Value (in Billion US$), 2010-2015

Figure 6 3: US: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2016-2021

Figure 6 4: US: Pharmaceutical Market: Sales Volume (in Billion Units), 2016-2021

Figure 6 5: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %),

2010 and 2015


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report Description and Highlights

Report Description

Figure 6 6: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %),

2010 and 2015

Figure 6 9: US: Generic Drug Market: Sales Volume (in Billion Units), 2010-2015

Figure 6 10: US: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2016-2021

Figure 6 7: US: Generic Drug Market: Sales Value (in Billion US$), 2010-2015

Figure 6 8: US: Generic Drug Market Forecast: Sales Value (in Billion US$), 2016-2021

Figure 6 11: US: Generic Drug Market: Market Breakup by Segment (in %), 2010-2015

Figure 7 1: US: Generic Drug Market: Sales Share of Top Players (in %), 2015

Figure 7 2: US: Generic Drug Market: Volume Share of Top Players (in %), 2015

Figure 7 3: US: Generic Drug Market: Volume Share by Distribution (in %), 2015

Figure 7 4: US: Generic Drug Prices as a Percentage of Branded Drug Prices – Based on Number of

Competitors

Figure 8 1: US: Generic Drug Market: Value Chain Analysis

List of Tables

Table 4 1: US: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion

US$)

Table 4 2: US: Price Differential between Generics and Innovator Drugs (in %)

Table 5 1: Sales Volume and Growth in Major Markets, 2015

Table 5 2: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2015


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report Description and Highlights

Report Description

Table 5 3: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million

Prescriptions), 2015

Table 7 1: Sales Performance of Top Players (in Billion US$), 2015

Table 7 2: Volume Performance of Top Players (in Billion Units), 2015

Table 7 3: US: Generics Market: Volume Performance of Top Generic Drugs (in Million

Prescriptions), 2015

Table 9 1: US: Overview of Pharmaceutical Regulations


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report Description and Highlights

Report Description

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:

Email: [email protected]

Phone: +91-120-415-5099

IMARC Group North America:

Email: [email protected]

Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:

Email: [email protected]

Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/us-generics-market


Us generic drug market research report 2016 2021

Imarc

Imarc

www.imarcgroup.com

Report Description and Highlights

Report Description

© 2015 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of

International Market Analysis Research and Consulting (IMARC). No part of this publication may be

reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be

used in any form or by and means graphic electronic or mechanical, including photocopying, recording,

taping or by information storage or retrieval, or by any other form, without the express consent of

International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been

based on information and sources believed to be accurate and reliable at the time of publishing.

International Market Analysis Research and Consulting makes no representation of warranty of any kind as to

the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any

loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market

Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of

their respective companies.


Us generic drug market research report 2016 2021

Contact Us

FOR MORE DETAILS

Visit us at :

http://www.imarcgroup.com

Stay With Us:

TELEPHONE: +91-120-4155099

E-MAIL: [email protected]


  • Login